Central Trust CO Bio Techne Corp Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Bio Techne Corp stock. As of the latest transaction made, Central Trust CO holds 979 shares of TECH stock, worth $73,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares

979

Previous 978 0.1%

Holding current value

$73,297

Previous $70,000 11.43%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$70.96 - $82.35 $70 - $82	1 Added 0.1%	979 $78,000
Q2 2024 Aug 05, 2024	SELL	$62.12 - $84.15 $621 - $841	-10 Reduced 1.01%	978 $70,000
Q3 2023 Oct 26, 2023	SELL	$67.52 - $89.42 $4,051 - $5,365	-60 Reduced 5.73%	988 $67,000
Q2 2023 Jul 26, 2023	SELL	$73.76 - $85.98 $2,950 - $3,439	-40 Reduced 3.68%	1,048 $85,000
Q4 2022 Jan 26, 2023	BUY	$80.67 - $352.29 $64,374 - $281,127	798 Added 275.17%	1,088 $0
Q4 2021 Feb 08, 2022	BUY	$456.15 - $525.06 $105,826 - $121,813	232 Added 400.0%	290 $150,000
Q2 2021 Jul 23, 2021	SELL	$387.35 - $450.26 $3,873 - $4,502	-10 Reduced 14.71%	58 $26,000
Q1 2021 Apr 23, 2021	SELL	$314.62 - $411.0 $2,202 - $2,877	-7 Reduced 9.33%	68 $25,000
Q3 2020 Oct 22, 2020	SELL	$232.22 - $282.96 $696 - $848	-3 Reduced 3.85%	75 $18,000
Q2 2020 Jul 14, 2020	SELL	$185.43 - $279.56 $4,079 - $6,150	-22 Reduced 22.0%	78 $20,000
Q2 2019 Jul 12, 2019	SELL	$188.72 - $215.43 $3,774 - $4,308	-20 Reduced 16.67%	100 $0
Q1 2019 Apr 26, 2019	SELL	$136.09 - $200.44 $45,862 - $67,548	-337 Reduced 73.74%	120 $0
Q4 2018 Jan 08, 2019	SELL	$132.75 - $203.8 $497,812 - $764,250	-3,750 Reduced 89.14%	457 $66,000
Q3 2018 Oct 04, 2018	SELL	$147.44 - $204.11 $9,583 - $13,267	-65 Reduced 1.52%	4,207 $0
Q1 2018 Apr 04, 2018	BUY	$131.46 - $151.04 $561,597 - $645,242	4,272 New	4,272 $0

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account